{"id":"W2917537905","doi":"10.1200/jco.18.00605","title":"First-Line Treatment of Patients With Indolent Non-Hodgkin Lymphoma or Mantle-Cell Lymphoma With Bendamustine Plus Rituximab Versus R-CHOP or R-CVP: Results of the BRIGHT 5-Year Follow-Up Study","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":307,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Ottawa Hospital","funders":"","keywords":"Medicine; Rituximab; Vincristine; Bendamustine; Mantle cell lymphoma; CHOP; Internal medicine; Hazard ratio; Prednisone; Cyclophosphamide; Oncology; Gastroenterology; Lymphoma; Surgery; Chemotherapy; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008610602,0.0004399536,0.003049276,0.0001718063,0.00007454252,0.00001110791,0.0003455385,0.0003189397,0.0001582798],"category_scores_gemma":[0.0006152607,0.000176294,0.000600382,0.0003931539,0.0002723126,0.0001050932,0.0001141076,0.0001821551,0.00002409172],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001036229,"about_ca_system_score_gemma":0.003593068,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003474299,"about_ca_topic_score_gemma":0.001413382,"domain_scores_codex":[0.9945493,0.0003571587,0.003105472,0.0004840318,0.001099575,0.0004045126],"domain_scores_gemma":[0.9909698,0.003157403,0.003785215,0.0007940534,0.0009174628,0.0003760443],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.4224286,0.08021083,0.4539815,0.00008239836,0.002333154,0.0008833752,0.0006494746,0.00007006493,0.000002966151,0.00000469799,0.0004548262,0.03889813],"study_design_scores_gemma":[0.3414618,0.1701364,0.4803778,0.0002816871,0.001690729,0.00005752575,0.0003264569,0.00003297683,0.0002371454,0.000001226631,0.005281755,0.0001144795],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944083,0.000103678,0.000003992024,0.0007762222,0.001487213,0.00194701,0.00009204274,0.0000085464,0.001172962],"genre_scores_gemma":[0.9968568,0.0003865592,0.0009215875,0.0001535688,0.0003120879,0.00002931083,0.00001454139,0.0000471587,0.001278393],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08992557,"threshold_uncertainty_score":0.718906,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06547427927673023,"score_gpt":0.3718566737576587,"score_spread":0.3063823944809285,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}